TAOX

+ Watchlist + Portfolio

Tao Synergies Inc.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $3.38
52-Week Range: $3.07 – $10.00
Market Cap: $27.54M
P/E (TTM): 2.23
EPS (TTM): 1.65
Dividend Yield: —

Advanced Metrics

Price/Book: 1.18
PEG Ratio: —
Return on Equity: -94.45%
Return on Assets: -26.07%
Gross Margin: 100.00%
Operating Margin: -1770.63%
Profit Margin: 0.00%
Current Ratio: 19.98
Debt/Equity: —
Total Debt: $0.00
Free Cash Flow: $-15.17M
Revenue Growth: 2136.90%
Earnings Growth: —
Enterprise Value: $27.47M

TAOX Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$0.00	$0.00	$0.00	$299.06K
Research & Development	$6.32M	$1.97M	$1.60M	$322.23K
Selling, General & Admin	$9.81M	$6.34M	$5.21M	$9.02M
Operating Expenses	$16.13M	$8.31M	$6.81M	$9.35M
Operating Income	-$16.13M	-$8.31M	-$6.81M	-$9.05M
EBITDA	-$16.13M	-$8.31M	-$6.81M	-$9.04M
Pretax Income	-$5.57M	-$6.04M	-$12.77M	-$28.74M
Income Tax	$0.00	$0.00	$0.00	$0.00
Net Income	-$5.57M	-$6.04M	-$12.77M	-$28.74M
Diluted EPS	-20.25	-29.56	-10.99	-8.81
Diluted Shares	279568	466100	1.23M	3.30M

TAOX Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$37.48M	$28.66M	$17.66M	$5.50M
Current Assets	$38.59M	$30.53M	$17.72M	$25.38M
Total Assets	$38.61M	$31.11M	$17.73M	$25.84M
Current Liabilities	$1.31M	$4.28M	$1.01M	$1.81M
Total Liabilities	$3.19M	$5.53M	$10.96M	$3.94M
Retained Earnings	-$19.83M	-$33.61M	-$47.17M	-$76.20M
Shareholders' Equity	$35.41M	$25.58M	$6.78M	$21.90M
Working Capital	$37.27M	$26.26M	$16.71M	$23.56M

TAOX Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	-$11.21M	-$5.17M	-$4.88M	-$6.40M
Capital Expenditure	-$7.41K	-$2.71K	—	—
Free Cash Flow	-$11.22M	-$5.18M	-$4.88M	-$6.40M
Depreciation & Amortisation	$5.71K	$6.35K	$5.58K	$3.62K
Stock-Based Compensation	$3.74M	$1.01M	$25.41K	$1.39M
Investing Cash Flow	-$7.41K	-$2.00M	-$1.00M	-$28.89M
Financing Cash Flow	$14.48M	-$1.64M	-$5.12M	$23.13M
Dividends Paid	$0.00	-$641.07K	-$950.92K	-$262.09K
Share Repurchases	$0.00	-$1.00M	-$8.63M	-$1.43M
Net Change in Cash	$3.26M	-$8.82M	-$11.01M	-$12.16M

TAOX Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$0.00	$3.96K	$203.37K	$91.73K	$388.77K
Research & Development	$60.82K	$148.56K	$54.39K	$58.47K	$28.60K
Selling, General & Admin	$1.01M	$2.19M	$1.95M	$3.88M	$1.68M
Operating Expenses	$1.07M	$2.34M	$2.00M	$3.93M	$1.71M
Operating Income	-$1.07M	-$2.34M	-$1.80M	-$3.84M	-$1.32M
EBITDA	-$1.07M	-$2.34M	-$1.80M	-$3.84M	-$1.32M
Pretax Income	$385.17K	-$17.52M	-$3.92M	-$7.68M	$4.25M
Income Tax	$0.00	$0.00	$0.00	$0.00	$0.00
Net Income	$385.17K	-$17.52M	-$3.92M	-$7.68M	$4.25M
Diluted EPS	0.04	-11.26	-1.56	—	0.43
Diluted Shares	1.39M	1.57M	2.55M	—	7.70M

TAOX Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$14.83M	$14.37M	$1.45M	$5.50M	$3.65M
Current Assets	$15.32M	$19.78M	$18.35M	$25.38M	$30.24M
Total Assets	$15.33M	$19.79M	$18.36M	$25.84M	$31.05M
Current Liabilities	$210.66K	$964.26K	$1.04M	$1.81M	$1.10M
Total Liabilities	$8.88M	$1.83M	$1.69M	$3.94M	$4.88M
Retained Earnings	-$46.89M	-$64.50M	-$68.47M	-$76.20M	-$72.15M
Shareholders' Equity	$6.45M	$17.96M	$16.67M	$21.90M	$26.16M
Working Capital	$15.11M	$18.82M	$17.31M	$23.56M	$29.14M

TAOX Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	-$2.00M	-$749.07K	-$1.19M	-$2.45M	-$1.68M
Free Cash Flow	-$2.00M	-$749.07K	-$1.19M	-$2.45M	-$1.68M
Depreciation & Amortisation	$1.03K	$979.00	$803.00	$802.00	$816.00
Stock-Based Compensation	$3.71K	$969.23K	-$333.35K	$753.68K	$76.60K
Investing Cash Flow	$0.00	-$4.50M	-$13.07M	-$11.32M	—
Financing Cash Flow	-$822.36K	$4.79M	$1.34M	$17.83M	-$169.01K
Dividends Paid	-$107.36K	-$97.80K	$0.00	-$56.93K	-$169.01K
Share Repurchases	-$715.00K	-$715.00K	$0.00	$0.00	$0.00
Net Change in Cash	-$2.82M	-$463.55K	-$12.92M	$4.05M	-$1.85M

Market Snapshot

About

Tao Synergies is a development-stage company focused on building a portfolio of businesses across various sectors including technology, healthcare, and consumer products. The company seeks to identify and develop synergistic business opportunities through strategic acquisitions and partnerships.